Post Reply
81-100 of 1133
Blocking at 32-34 at 2 mils each, BBs in control.
Hope it?s not SSH unloading.
Grubber ( Date: 16-May-2023 10:51) Posted:
|
short at 31 try try
OUE LIPPO HEALTHCARE TO OPERATE INTERNATIONAL MEDICAL CENTRE IN PARTNERSHIP WITH CHINESE UNIVERSITY OF HONG KONG &bull
CUHK to provide management consultancy services for the development, commissioning, clinical governance, and management of an international medical centre in Prince Bay Hospital
17 April 2023 &ndash OUE Lippo Healthcare Limited (&ldquo OUELH&rdquo or the &ldquo Company&rdquo and together with its subsidiaries, the &ldquo Group&rdquo ) announced today that they have entered into a service agreement with the Chinese University of Hong Kong (&ldquo CUHK&rdquo ) via its joint venture (&ldquo JV&rdquo ) company, China Merchants Lippo Hospital Management (Shenzhen) Limited (&ldquo CM Lippo&rdquo ). Under the service agreement, CUHK will provide management consultancy services for the development, commissioning, clinical governance, and management of an international medical centre (&ldquo Prince Bay IMC&rdquo ) in Shenzhen China Merchants-Lippo Prince Bay Hospital (the &ldquo Prince Bay Hospital&rdquo ) in Shekou, Shenzhen. 2 The Prince Bay IMC will be located within the premises of the Prince Bay Hospital, which is positioned as an international high-end general hospital serving the growing local affluent population in the Guangdong-Hong Kong-Macao Greater Bay Area (the &ldquo Greater Bay Area&rdquo ). With this partnership, CUHK will assist in the development of the Prince Bay IMC including manpower planning of doctors, development of clinical specialties, clinical governance, operating system and workflow development. CUHK will also facilitate the credentialing and provision of education for healthcare professionals providing services in the Prince Bay IMC, as well as the development of green channel for cross border referral to hospitals within the network of CUHK and its affiliated hospitals. Chief Executive Officer of OUELH, Mr Yet Kum Meng said, &ldquo This partnership with CUHK is a testament of our commitment to operate the Prince Bay Hospital based on international medical standards offering high-quality healthcare services for the residents in the Greater Bay Area. We believe that the medical expertise and international medical resources from CUHK will enhance the healthcare service offerings of Prince Bay Hospital and improve patient experience.&rdquo &ldquo We are delighted to partner with Shenzhen China Merchants-Lippo Prince Bay Hospital to help establish the Prince Bay IMC. This partnership is in line with our academic, research objectives and community spirit to bring world-class research and innovative solutions from CUHK to make tangible societal and economic impact,&rdquo remarked Professor Justin Wu Che Yuen, Associate Dean (Health Systems) from CUHK1 , who has been assigned to provide management consultancy services to the Prince Bay IMC. Prince Bay Hospital is expected to be commissioned in 2024 with more than 200 beds.
CUHK to provide management consultancy services for the development, commissioning, clinical governance, and management of an international medical centre in Prince Bay Hospital
17 April 2023 &ndash OUE Lippo Healthcare Limited (&ldquo OUELH&rdquo or the &ldquo Company&rdquo and together with its subsidiaries, the &ldquo Group&rdquo ) announced today that they have entered into a service agreement with the Chinese University of Hong Kong (&ldquo CUHK&rdquo ) via its joint venture (&ldquo JV&rdquo ) company, China Merchants Lippo Hospital Management (Shenzhen) Limited (&ldquo CM Lippo&rdquo ). Under the service agreement, CUHK will provide management consultancy services for the development, commissioning, clinical governance, and management of an international medical centre (&ldquo Prince Bay IMC&rdquo ) in Shenzhen China Merchants-Lippo Prince Bay Hospital (the &ldquo Prince Bay Hospital&rdquo ) in Shekou, Shenzhen. 2 The Prince Bay IMC will be located within the premises of the Prince Bay Hospital, which is positioned as an international high-end general hospital serving the growing local affluent population in the Guangdong-Hong Kong-Macao Greater Bay Area (the &ldquo Greater Bay Area&rdquo ). With this partnership, CUHK will assist in the development of the Prince Bay IMC including manpower planning of doctors, development of clinical specialties, clinical governance, operating system and workflow development. CUHK will also facilitate the credentialing and provision of education for healthcare professionals providing services in the Prince Bay IMC, as well as the development of green channel for cross border referral to hospitals within the network of CUHK and its affiliated hospitals. Chief Executive Officer of OUELH, Mr Yet Kum Meng said, &ldquo This partnership with CUHK is a testament of our commitment to operate the Prince Bay Hospital based on international medical standards offering high-quality healthcare services for the residents in the Greater Bay Area. We believe that the medical expertise and international medical resources from CUHK will enhance the healthcare service offerings of Prince Bay Hospital and improve patient experience.&rdquo &ldquo We are delighted to partner with Shenzhen China Merchants-Lippo Prince Bay Hospital to help establish the Prince Bay IMC. This partnership is in line with our academic, research objectives and community spirit to bring world-class research and innovative solutions from CUHK to make tangible societal and economic impact,&rdquo remarked Professor Justin Wu Che Yuen, Associate Dean (Health Systems) from CUHK1 , who has been assigned to provide management consultancy services to the Prince Bay IMC. Prince Bay Hospital is expected to be commissioned in 2024 with more than 200 beds.
Laggard play.....Have not moved. Got chance today. A bit of volume
OUE Lippo Healthcare reports higher revenue, lower profits due to exceptional items
CATALIST-LISTED OUE Lippo Healthcare : 5WA +3.13% (OUELH) on Friday (Aug 5) posted a 93 per cent drop in net profit to S$8.4 million for its half year ended Jun 30, 2022, from S$113.8 million a year earlier. Its revenue, however, was several times that of the previous years: S$42.6 million for H1 FY2022, versus S$9.7 million for H1 FY2021.
The company&rsquo s financial statement was laden with exceptional items, reflective of a restructuring and the shuffling of control of assets among related companies by the healthcare group&rsquo s parent OUE.
Most of the increase in OUELH&rsquo s revenue came from the consolidation of First Reit : AW9U 0%, a healthcare Reit within the OUE stable.
On Mar 1, OUELH had sold 2 subsidiaries to First Reit in exchange for units of First Reit. The deal took OUELH&rsquo s stake in First Reit from 15.3 per cent to 33.1 per cent. The change in ownership allows OUELH to consolidate First Reit&rsquo s revenue into its own.
The transaction was also accounted for as a disposal of an associate, and allowed OUELH to recognise a net gain of S$3.1 million.
On top of this, OUELH recognised a fair value gain of S$4.2 million on First Reit&rsquo s investment properties.
Both items were reported as other income in OUELH&rsquo s statements, and should have boosted the company&rsquo s profits. But OUELH had booked a far larger exceptional item in the year-ago period.
Its net profit of S$113.8 million for H1 FY2021 was boosted by a one-off S$110 million gain from a shareholder loan conversion.
On Mar 16, 2021, OUELH had converted a total of S$189.6 million in loans and accrued interest owing to its parent, OUE, into convertible perpetual securities. OUELH booked a one-off gain representing the difference between the principal amount and the fair value of the perps, of S$79.6 million.
Stripping out these transactions and exceptional items, OUELH&rsquo s healthcare operations reported revenue of S$2 million &mdash up from S$1.2 million. Segment losses widened, too, to S$1 million from S$892,000.
Is this counter a good buy?
UPDATE ON THE PROPOSED PARTNERSHIP WITH GROUP OF RESPIRATORY AND CARDIOTHORACIC MEDICAL PRACTICES IN SINGAPORE
Unless otherwise defined, all capitalised terms used herein shall have the meanings ascribed to them in the announcement dated 23 May 2022 (the " 23 May Announcement" ). The Board of Directors (the " Board" ) of OUE Lippo Healthcare Limited (the " Company" ) refers to the 23 May Announcement in relation to the (a) establishment of a joint venture company known as Echo Healthcare Management Pte. Ltd. (the " OUE JV" ) with OUE Limited and (b) proposed formation of a joint venture with (i) RMA Med Holdings Pte. Ltd. (" RMA HoldCo" ) (ii) TRP Holdings Pte. Ltd. (" TRP HoldCo" ) and (iii) Witty Hearty Lungs Pte. Ltd. (" BH HoldCo" and together with RMA HoldCo and TRP HoldCo, the " Founders" ) to create a partnership with (i) RMA Global Pte. Ltd. (" RMA" ), (ii) The Respiratory Practice (Farrer) Pte. Ltd. (" TRPF" ), and (iii) Breathing Heart Pte. Ltd. (" BH" , and together with RMA and TRPF, the " Medical Partners" ) (the " Proposed Transaction" ). The Board is pleased to announce that all the conditions precedent under the MSSPA have been fulfilled and/or waived in accordance with the terms of the MSSPA, and accordingly, the Proposed Transaction was completed today.
Unless otherwise defined, all capitalised terms used herein shall have the meanings ascribed to them in the announcement dated 23 May 2022 (the " 23 May Announcement" ). The Board of Directors (the " Board" ) of OUE Lippo Healthcare Limited (the " Company" ) refers to the 23 May Announcement in relation to the (a) establishment of a joint venture company known as Echo Healthcare Management Pte. Ltd. (the " OUE JV" ) with OUE Limited and (b) proposed formation of a joint venture with (i) RMA Med Holdings Pte. Ltd. (" RMA HoldCo" ) (ii) TRP Holdings Pte. Ltd. (" TRP HoldCo" ) and (iii) Witty Hearty Lungs Pte. Ltd. (" BH HoldCo" and together with RMA HoldCo and TRP HoldCo, the " Founders" ) to create a partnership with (i) RMA Global Pte. Ltd. (" RMA" ), (ii) The Respiratory Practice (Farrer) Pte. Ltd. (" TRPF" ), and (iii) Breathing Heart Pte. Ltd. (" BH" , and together with RMA and TRPF, the " Medical Partners" ) (the " Proposed Transaction" ). The Board is pleased to announce that all the conditions precedent under the MSSPA have been fulfilled and/or waived in accordance with the terms of the MSSPA, and accordingly, the Proposed Transaction was completed today.
FULL & FINAL SETTLEMENT WITH CREST ENTITIES ON PROCEEDINGS RELATED TO FACILITY AGREEMENTS
The Company has received the above balance payment of S$200,000 from Crest. Upon receipt of the said balance payment, there are no further outstanding instalments due from Crest under the Settlement Agreement. There are also no other pending or outstanding claims between the Company and Crest.
Never move up much only 38. Limited range.
SmallSmall ( Date: 07-Jun-2022 09:33) Posted:
|
Rebound. Day trade?
RATIONALE AND KEY BENEFITS OF THE PROPOSED TRANSACTION
The Board believes that the Proposed Transaction is in the interests of the Company for the following reasons:
(a) Building a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices The Proposed Transaction is an important milestone for the Company to build a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices and create potential synergistic growth opportunities. The Company will be able to leverage on the Medical Partners&rsquo clinical expertise to elevate the overall healthcare standards and quality in the Company&rsquo s growing regional healthcare network. (
b) Win-win arrangement in ensuring sustainable regional growth for all stakeholders The Proposed Transaction is structured such that while the Medical Partners will be integrated into the Company' s healthcare network, they will retain clinical independence in their respective practices, thereby aligning long-term objective of all stakeholders to ensure sustainable growth. (
c) Enhances shareholder value Based on the Medical Partners' financial results for the past three (3) financial years, the Medical Partners are earnings accretive with a stable and growing stream of recurring income and cash flow, which the Company envisages will enhance long term shareholder value.
The Board believes that the Proposed Transaction is in the interests of the Company for the following reasons:
(a) Building a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices The Proposed Transaction is an important milestone for the Company to build a regional healthcare ecosystem anchored on Singapore&rsquo s medical best practices and create potential synergistic growth opportunities. The Company will be able to leverage on the Medical Partners&rsquo clinical expertise to elevate the overall healthcare standards and quality in the Company&rsquo s growing regional healthcare network. (
b) Win-win arrangement in ensuring sustainable regional growth for all stakeholders The Proposed Transaction is structured such that while the Medical Partners will be integrated into the Company' s healthcare network, they will retain clinical independence in their respective practices, thereby aligning long-term objective of all stakeholders to ensure sustainable growth. (
c) Enhances shareholder value Based on the Medical Partners' financial results for the past three (3) financial years, the Medical Partners are earnings accretive with a stable and growing stream of recurring income and cash flow, which the Company envisages will enhance long term shareholder value.
This one will eventually be transformed into a mega healthcare play by the Lippo Group.
Still gestation period. NAV $0.0551.
Still gestation period. NAV $0.0551.
Joelton ( Date: 25-May-2022 09:36) Posted:
|
OUE Lippo Healthcare up 5.3% on new healthcare partnership
SHARES of OUE Lippo Healthcare closed higher on Tuesday (May 24), after the healthcare group said it will form new partnerships to add to its healthcare network.
The counter gained as much as 18.4 per cent or S$0.007 to trade at S$0.045 as at 9.04 am, before closing 5.3 per cent or S$0.002 higher at S$0.04 on Tuesday.
No married deals were recorded, according to ShareInvestor data.
As at 9.43 am, its shares have eased slightly to trade at S$0.041, up 7.9 per cent or S$0.003. Some 12.3 million shares worth S$540,000 changed hands.
On Monday, OUE Lippo Healthcare said Echo Healthcare Management, its joint venture with OUE, has formed a partnership called Echo Healthcare Services with 3 medical specialist groups.
The 3 partners include Respiratory Medical Associates (RMA) and The Respiratory Practice (TRP), which provide treatment for lung, sleep and allergy disorders, and Thoracic & Cardiovascular Surgery Specialists (TCSS), which provides cardiac and thoracic surgery.
Echo Healthcare Management will hold a 60 per cent stake in the new joint venture, while the founders of the medical specialists groups will hold the remaining 40 per cent stake collectively.
Echo Healthcare Services will also hold a 60 per cent stake in each of the medical specialists groups.
The total aggregate purchase price for all 3 specialist medical groups is S$31 million, comprising S$6.5 million for RMA&rsquo s shares, S$8.3 million for TRP&rsquo s shares and S$16.2 million for TCSS&rsquo shares, and payable with a mix of shares and cash.
The board of directors expects the company to tap on the medical specialists to elevate the overall healthcare standards and quality of OUE&rsquo s regional healthcare network. The medical partners will also be integrated into the healthcare network while retaining their clinical independence in their own practices.
Yes!!!
Any bro playing this? Can get more at 4 cents?
Bought! I hope it will be played up! 🙏 🙏 🙏
EPS of 2.5 cents translates to PE 1.8 at 4.5 cents In healthcare business and got joint venture. Rise only this little?
SHARES of OUE Lippo Healthcare jumped in the morning on Tuesday (May 24), after the healthcare group said it will form new partnerships to add to its healthcare network.
The counter gained as much as 18.4 per cent or S$0.007 to trade at S$0.045 as at 9.04 am.
No married deals were recorded, according to ShareInvestor data.
As at 9.43 am, its shares have eased slightly to trade at S$0.041, up 7.9 per cent or S$0.003. Some 12.3 million shares worth S$540,000 changed hands.
On Monday, OUE Lippo Healthcare said Echo Healthcare Management, its joint venture with OUE, has formed a partnership called Echo Healthcare Services with 3 medical specialist groups.
The 3 partners include Respiratory Medical Associates (RMA) and The Respiratory Practice (TRP), which provide treatment for lung, sleep and allergy disorders, and Thoracic & Cardiovascular Surgery Specialists (TCSS), which provides cardiac and thoracic surgery.
Echo Healthcare Management will hold a 60 per cent stake in the new joint venture, while the founders of the medical specialists groups will hold the remaining 40 per cent stake collectively.
Echo Healthcare Services will also hold a 60 per cent stake in each of the medical specialists groups.
The total aggregate purchase price for all 3 specialist medical groups is S$31 million, comprising S$6.5 million for RMA&rsquo s shares, S$8.3 million for TRP&rsquo s shares and S$16.2 million for TCSS&rsquo shares, and payable with a mix of shares and cash.
The board of directors expects the company to tap on the medical specialists to elevate the overall healthcare standards and quality of OUE&rsquo s regional healthcare network. The medical partners will also be integrated into the healthcare network while retaining their clinical independence in their own practices.
Queued at 41